What is Carlisle Companies's other accrued liabilities?

Carlisle Companies (CSL) reported other accrued liabilities of $503M in Q4 2025.

Carlisle Companies CSL Other accrued liabilities

Other accrued liabilities at other companies

CoStar GroupCSGP

$216M-8.4%

Edwards LifesciencesEW

$1.2B+0.6%

Planet LabsPL

$58.54M+103%

SamsaraIOT

$112.22M+32.9%

AllstateALL

$13.24B+33.7%

CelesticaCLS

$1.9B+18.1%

Other financials

Income statement

See full

Revenue$1.1B-4.0%

Gross profit$363.2M-5.8%

Operating income$180.3M-1.8%

Net income$127.7M-10.9%

EPS (diluted)$3.10-3.1%

Balance sheet

See full

Cash & equivalents$771.3M+250%

Total debt$2.9B+52.5%

Total equity$1.7B-23.7%

Total assets$6.0B+9.9%

Cash flow

See full

Operating cash flow-$44.7M-2,583%

CapEx$28.3M-2.4%

Free cash flow-$73.0M-168%

Valuation

See full

Market cap$14.61B-9.3%

Enterprise value$16.72B-5.7%

P/E20.1×+7.4×

P/S2.9×-0.3×

Profitability

See full

Gross margin35.6%-1.9pp

Operating margin20.1%-1.9pp

Net margin14.6%-10.7pp

FCF margin18.6%+3.4pp

Returns & leverage

See full

Return on equity38%-12.3pp

Debt / equity1.7×+0.9×

Current ratio3.4×+0.8×

Where this comes from

Reported directly by Carlisle Companies in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Carlisle Companies’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Carlisle Companies's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Carlisle Companies's other accrued liabilities?: Carlisle Companies (CSL) reported other accrued liabilities of $503M in Q4 2025.